Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia

Pediatric and Developmental Pathology

Volumn 5, Issue 3, 2002, Pages 269-275

  Kletzel, Morris ^a   Olzewski, Marie ^a   Huang, Wei ^a   Chou, Pauline M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone marrow transplant; Minimal residual disease; Pediatric leukemia; WT1

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR WT1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ARTICLE; BLAST CELL CRISIS; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CELL STRAIN K 562; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NEPHROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; WT1 GENE;

ADOLESCENT; ADULT; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 0036294886     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-001-0208-x     Document Type: Article

References (31)

1. Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping
2. WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant
3. The role of WT1 in Wilms' tumorigenesis
4. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma
5. Molecular mechanism possibly affecting WT1 function in human ovarian tumors
6. The Wilms' tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma
7. Expression of the WT1 Wilm's tumor gene by normal and malignant human melanocytes
8. The WT1 Wilms' tumor product: A developmentally regulated transcription factors in the kidney that functions as a tumor suppressor
9. Isolation characterization and expression of the murine Wilms' tumor gene (WT1) during kidney development
10. The expression of the Wilm's tumor gene WT1 in the developing mammalian embryo
11. Expression of the Wilms' tumor gene WT1 in human leukemias
12. Expression of the candidate Wilms' tumor gene WT1 in human leukemia cells
13. Presence of Wilms tumor gene (WT1 transcripts of WT1 nuclear protein in the majority of human acute leukemias
14. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemia blast cells
15. WT1 gene expression in childhood acute leukemias
16. Wilms' tumor gene (WT1) as a new marker for the detection of minimal residual disease in leukemia
17. WT1 a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
18. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
19. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
20. Detection of a minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementary-determining region (CDRIII)-specific probes
21. Detection of minimal residual disease in acute leukemia by flow cytometry
22. Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia
23. A polymerase chain reaction study of the stability of IG heavy chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia
24. Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific
25. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
26. Wilm's tumor gene (WT1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukemia treated by an intensive chemotherapy protocol
27. Expression of the Wilm's tumor gene (WT1) in normal hematopoiesis
28. Downregulation of Wilm's tumor gene (wt1) during myelomonocytic differentiation in HL60 cells
29. The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro
30. Expression of the Wilm's tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice
31. Selective elimination of leukemia CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1